We are live on
!
Find out more
CBU
CIBC Bancorp USA Portfolio holdings
AUM
$82.3B
This Fund
S&P 500
This Quarter
Est. Return
+20.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$82.3B
AUM Growth
+$7.86B
(+11%)
Cap. Flow
-$944M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
26.31%
Holding
2,056
New
305
Increased
737
Reduced
780
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$619M |
| 2 |
Flutter Entertainment
FLUT
|
+$527M |
| 3 |
Micron Technology
MU
|
+$319M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$297M |
| 5 |
Robinhood
HOOD
|
+$197M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$418M |
| 3 |
Amazon
AMZN
|
+$411M |
| 4 |
Microsoft
MSFT
|
+$358M |
| 5 |
Apple
AAPL
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.78% |
| 2 | Financials | 10.07% |
| 3 | Industrials | 10.04% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Healthcare | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Sana Biotechnology
SANA
$1.06B
| $35.4K | ﹤0.01% |
+10,140
| New | +$32.7K |
|
1902
Embecta
EMBC
$289M
| $34.9K | ﹤0.01% |
10,696
+410
| +4% | +$2.24K |
|
1903
Opko Health
OPK
$1.03B
| $33.4K | ﹤0.01% |
22,249
+1,528
| +7% | +$1.95K |
|
1904
Altimmune
ALT
$572M
| $33.4K | ﹤0.01% |
+10,974
| New | +$32.8K |
|
1905
Lexicon Pharmaceuticals
LXRX
$1.03B
| $33K | ﹤0.01% |
13,740
-1,786,260
| -99% | -$3.48M |
|
1906
Bit Digital
BTBT
$566M
| $32.7K | ﹤0.01% |
18,165
+632
| +4% | +$1.11K |
|
1907
Cerus
CERS
$601M
| $32.1K | ﹤0.01% |
+10,984
| New | +$26.6K |
|
1908
Allogene Therapeutics
ALLO
$708M
| $30.5K | ﹤0.01% |
+14,653
| New | +$32.2K |
|
|
NXDR
1909
Nextdoor Holdings
NXDR
$998M
| $29.4K | ﹤0.01% |
12,951
+1,751
| +16% | +$3.27K |
|
1910
Solid Power
SLDP
$552M
| $29K | ﹤0.01% |
+11,202
| New | +$34.6K |
|
1911
Ocugen
OCGN
$458M
| $28.9K | ﹤0.01% |
+18,869
| New | +$28.7K |
|
|
URG
1912
Ur-Energy
URG
$537M
| $28.6K | ﹤0.01% |
+21,018
| New | +$34.3K |
|
1913
Pacific Biosciences
PACB
$357M
| $27.2K | ﹤0.01% |
16,193
+1,679
| +12% | +$2.44K |
|
1914
Richtech Robotics
RR
$402M
| $22K | ﹤0.01% |
10,431
-2,447
| -19% | -$5.94K |
|
1915
Laser Photonics
LASE
$74.3M
| $21.4K | ﹤0.01% |
+13,000
| New | +$17.8K |
|
|
OPTU
1916
Optimum Communications Inc
OPTU
$251M
| $21.3K | ﹤0.01% |
14,719
+1,555
| +12% | +$1.93K |
|
1917
Palisade Bio
PALI
$373M
| $21.2K | ﹤0.01% |
+10,148
| New | +$20K |
|
1918
Gevo
GEVO
$418M
| $19.8K | ﹤0.01% |
13,198
+1,414
| +12% | +$2.49K |
|
1919
Blend Labs
BLND
$352M
| $17.4K | ﹤0.01% |
+10,174
| New | +$16.2K |
|
1920
Akebia Therapeutics
AKBA
$242M
| $16.3K | ﹤0.01% |
14,267
+1,517
| +12% | +$1.81K |
|
1921
Heartbeam
BEAT
$28.1M
| $15.5K | ﹤0.01% |
20,631
+10,000
| +94% | +$8.94K |
|
|
EU
1922
enCore Energy
EU
$235M
| $14.1K | ﹤0.01% |
+10,765
| New | +$18.1K |
|
1923
Microvast
MVST
$322M
| $13.7K | ﹤0.01% |
11,679
+1,653
| +16% | +$2.55K |
|
1924
SES AI
SES
$223M
| $13.4K | ﹤0.01% |
+13,915
| New | +$15.1K |
|
1925
Lineage Cell Therapeutics
LCTX
$271M
| $13.3K | ﹤0.01% |
+10,174
| New | +$14.1K |
|
Similar funds
QCM
CIBC Bancorp USA's Q2 2026 Portfolio in Review
As of Q2 2026, CIBC Bancorp USA held 2,056 positions worth $82.3B, up 11% from $74.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
CIBC Bancorp USA's Q2 2026 filing shows 305 new, 737 increased, 780 reduced and 129 closed positions. Its largest new stake was iShares MSCI Brazil ETF: 1,937,500 shares worth $66.8M. The largest sale was NVIDIA, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- CIBC Bancorp USA's largest Q2 2026 buy was iShares MSCI Brazil ETF: 1,937,500 shares worth $66.8M.
- CIBC Bancorp USA added most to DraftKings in Q2 2026, an estimated $619M increase.
- CIBC Bancorp USA's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $474M.
- CIBC Bancorp USA fully exited Bio-Rad Laboratories Class A in Q2 2026, selling an estimated $33.5M.
- CIBC Bancorp USA's ten largest holdings make up 26% of its $82.3B portfolio in Q2 2026.
- CIBC Bancorp USA opened 305 new positions and closed 129 in Q2 2026.
- CIBC Bancorp USA's portfolio value rose 11% quarter-over-quarter to $82.3B.
Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.